Active ingredients: panobinostat
What it is used for
Farydak, in combination with bortezomib and dexamethasone, is indicated for the treatment of adult patients with relapsed and/or refractory multiple myeloma who have received at least two prior regimens including bortezomib and an immunomodulatory agent.,Treatment with Farydak should be initiated and monitored by a specialist physician with expertise in managing haematological malignancies.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 30 degrees Celsius
- Store in Original Container
- Protect from Moisture
- Lifetime is 36 Months.
Always read the label. If symptoms persist see your healthcare professional.
Red opaque hard capsule. Radial markings on cap with black ink "LBH 20mg". Two radial bands with black ink on body. White to almost white powder.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)